Safety of Avonex Treatment in Multiple Sclerosis Patients With Neutralizing Antibodies to Interferon Beta Therapy

Clinical trial NCT00493077 · COMPLETED

Trial details

NCT number: NCT00493077
Sponsor: Biogen
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Multiple Sclerosis

Start date: 2004-05-01
Primary completion: 2006-05-01
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.